08:23 AM EST, 11/06/2025 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q2 earnings Thursday of $1.27 per diluted share, compared with $1.12 a year earlier.

Two analysts surveyed by FactSet expected $0.99.

Revenue for the quarter ended Sept. 27 was $327.3 million, compared with $345.5 million a year earlier. Analysts surveyed by FactSet expected $311.5 million.

The company raised the lower end of its 2026 adjusted EPS guidance to $4.80 to $5.00, up from $4.70 to $5.00 previously.

Shares of the healthcare company were up more than 12% pre-bell.